Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOLIPOP Trial
NCT05072314Phase 3Recruiting
- Sponsor
- Monash University
- Start
- Jul 2022
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in chronic postsurgical pain (CPSP), sponsored by Monash University. Started Jul 2022; status: recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
chronic postsurgical pain (CPSP)
Beyond the preview
Go deeper on NCT05072314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05072314.